The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 16, 2024

Filed:

Mar. 16, 2023
Applicant:

President and Fellows of Harvard College, Cambridge, MA (US);

Inventors:

Xiaowei Zhuang, Cambridge, MA (US);

Kok-Hao Chen, Cambridge, MA (US);

Alistair Boettiger, Cambridge, MA (US);

Jeffrey R. Moffitt, Cambridge, MA (US);

Siyuan Wang, Cambridge, MA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/10 (2006.01); C07H 21/02 (2006.01); C07H 21/04 (2006.01); C12Q 1/6806 (2018.01); C12Q 1/6837 (2018.01); C12Q 1/6841 (2018.01); C12Q 1/6869 (2018.01); G06N 7/01 (2023.01); G16B 25/00 (2019.01); G16B 25/20 (2019.01); G16B 40/10 (2019.01); G16C 20/10 (2019.01); C12Q 1/6816 (2018.01); G16B 30/00 (2019.01); G16B 40/00 (2019.01);
U.S. Cl.
CPC ...
C12N 15/1065 (2013.01); C07H 21/02 (2013.01); C07H 21/04 (2013.01); C12N 15/10 (2013.01); C12N 15/1093 (2013.01); C12Q 1/6806 (2013.01); C12Q 1/6837 (2013.01); G16B 25/00 (2019.02); G16B 25/20 (2019.02); G16B 40/10 (2019.02); G16C 20/10 (2019.02); C12Q 1/6816 (2013.01); C12Q 1/6841 (2013.01); C12Q 1/6869 (2013.01); G06N 7/01 (2023.01); G16B 30/00 (2019.02); G16B 40/00 (2019.02);
Abstract

The present invention generally relates to systems and methods for imaging or determining nucleic acids, for instance, within cells. In some embodiments, the transcriptome of a cell may be determined. Certain embodiments are directed to determining nucleic acids, such as mRNA, within cells at relatively high resolutions. In some embodiments, a plurality of nucleic acid probes may be applied to a sample, and their binding within the sample determined, e.g., using fluorescence, to determine locations of the nucleic acid probes within the sample. In some embodiments, codewords may be based on the binding of the plurality of nucleic acid probes, and in some cases, the codewords may define an error-correcting code to reduce or prevent misidentification of the nucleic acids. In certain cases, a relatively large number of different targets may be identified using a relatively small number of labels, e.g., by using various combinatorial approaches.


Find Patent Forward Citations

Loading…